Park Place Capital Corp boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 14.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,212 shares of the medical equipment provider’s stock after buying an additional 274 shares during the period. Park Place Capital Corp’s holdings in Intuitive Surgical were worth $1,155,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the business. Global Trust Asset Management LLC boosted its stake in Intuitive Surgical by 40.8% during the fourth quarter. Global Trust Asset Management LLC now owns 1,149 shares of the medical equipment provider’s stock valued at $600,000 after buying an additional 333 shares during the period. Advisory Alpha LLC lifted its stake in Intuitive Surgical by 25.7% during the fourth quarter. Advisory Alpha LLC now owns 2,147 shares of the medical equipment provider’s stock worth $1,121,000 after purchasing an additional 439 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Intuitive Surgical by 2.9% during the fourth quarter. Nisa Investment Advisors LLC now owns 115,225 shares of the medical equipment provider’s stock worth $60,143,000 after purchasing an additional 3,292 shares during the last quarter. Simon Quick Advisors LLC lifted its stake in Intuitive Surgical by 8.1% during the fourth quarter. Simon Quick Advisors LLC now owns 2,132 shares of the medical equipment provider’s stock worth $1,113,000 after purchasing an additional 160 shares during the last quarter. Finally, Beaumont Financial Advisors LLC lifted its stake in Intuitive Surgical by 26.0% during the fourth quarter. Beaumont Financial Advisors LLC now owns 678 shares of the medical equipment provider’s stock worth $354,000 after purchasing an additional 140 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Trading Up 0.8 %
ISRG stock opened at $609.02 on Wednesday. The stock has a market capitalization of $216.92 billion, a PE ratio of 97.70, a price-to-earnings-growth ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $606.50. The stock’s 50 day simple moving average is $543.14 and its 200 day simple moving average is $501.89.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on Intuitive Surgical
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 1,012 shares of the business’s stock in a transaction on Friday, October 25th. The shares were sold at an average price of $514.00, for a total transaction of $520,168.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,830,084. The trade was a 15.53 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 269 shares of the business’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total transaction of $145,230.41. Following the sale, the insider now owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,509 shares of company stock valued at $22,602,212. 0.80% of the stock is owned by corporate insiders.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Tempus AI: A Game-Changer in AI-Powered Healthcare
- What is a Secondary Public Offering? What Investors Need to Know
- Pelosi Bets Big on AI: This Is What You Need to Know
- The How and Why of Investing in Gold Stocks
- Mobileye’s High Short Interest Signals Squeeze Potential
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.